Development and validation of a computed tomography-based radiomics signature to predict “highest-risk” from patients with high-risk gastrointestinal stromal tumor

Background: Some patients with high-risk gastrointestinal stromal tumor (GIST) experience disease progression after complete resection and adjuvant therapy. It is of great significance to distinguish these patients among those with high-risk GIST. Radiomics has been demonstrated as a promising tool to predict various tumors prognosis.